Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker EHC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Andrew L. Price Chief Accounting Officer | EHC Encompass Health Corporation | Sale | 5,211 | $120.93 | $630.2K Sale | Form 4 ↗ |
| Aug 31, 2026 | John Patrick Darby EVP, Gen Counsel & Secretary | EHC Encompass Health Corporation | Sale | 4,858 | $121.09 | $588.3K Sale | Form 4 ↗ |
| Aug 10, 2026 | Douglas E. Coltharp EVP & Chief Financial Officer | EHC Encompass Health Corporation | Sale | 18,869 | $125.38 | $2.4M Sale | Form 4 ↗ |
| Aug 10, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 1,579 | $126.06 | $199.0K Sale | Form 4 ↗ |
| Aug 10, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 171,569 | $125.46 | $21.5M Sale | Form 4 ↗ |
| Aug 10, 2026 | John Patrick Darby EVP, Gen Counsel & Secretary | EHC Encompass Health Corporation | Sale | 8,906 | $125.95 | $1.1M Sale | Form 4 ↗ |
| May 15, 2026 | Douglas E. Coltharp EVP & Chief Financial Officer | EHC Encompass Health Corporation | Sale | 1 | $107.28 | $107 Sale | Form 4 ↗ |
| May 15, 2026 | Douglas E. Coltharp EVP & Chief Financial Officer | EHC Encompass Health Corporation | Sale | 27,693 | $106.83 | $3.0M Sale | Form 4 ↗ |
| May 11, 2026 | Patrick William Tuer EVP, Chief Operating Officer | EHC Encompass Health Corporation | Sale | 682 | $104.56 | $71.3K Sale | Form 4 ↗ |
| Mar 9, 2026 | Edmund Fay Sr. Vice Pres. and Treasurer | EHC Encompass Health Corporation | Sale | 11,937 | $107.00 | $1.3M Sale | Form 4 ↗ |
| Feb 11, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 213 | $113.58 | $24.2K Sale | Form 4 ↗ |
| Feb 11, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 87,745 | $113.09 | $9.9M Sale | Form 4 ↗ |
| Feb 11, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 6,057 | $111.89 | $677.7K Sale | Form 4 ↗ |
| Feb 11, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 10,954 | $110.92 | $1.2M Sale | Form 4 ↗ |
| Feb 11, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 15,584 | $110.07 | $1.7M Sale | Form 4 ↗ |
| Feb 11, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 13,231 | $108.80 | $1.4M Sale | Form 4 ↗ |
| Feb 11, 2026 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 16,216 | $108.03 | $1.8M Sale | Form 4 ↗ |
| Feb 10, 2026 | Patrick William Tuer EVP, Chief Operating Officer | EHC Encompass Health Corporation | Sale | 2,804 | $107.62 | $301.8K Sale | Form 4 ↗ |
| Aug 27, 2025 | Patrick William Tuer EVP, Chief Operating Officer | EHC Encompass Health Corporation | Sale | 1,020 | $123.59 | $126.1K Sale | Form 4 ↗ |
| May 20, 2025 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 118,290 | $121.53 | $14.4M Sale | Form 4 ↗ |
| May 20, 2025 | Mark J. Tarr President & CEO, Director | EHC Encompass Health Corporation | Sale | 94 | $120.94 | $11.4K Sale | Form 4 ↗ |
| May 6, 2025 | Elissa Joy Charbonneau Chief Medical Officer | EHC Encompass Health Corporation | Sale | 4,279 | $116.61 | $499.0K Sale | Form 4 ↗ |
| Apr 29, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | EHC Encompass Health Corporation | Sale | 10,000 | $114.79 | $1.1M Sale | Form 4 ↗ |
| Apr 29, 2025 | Douglas E. Coltharp EVP & Chief Financial Officer | EHC Encompass Health Corporation | Sale | 3,934 | $116.36 | $457.8K Sale | Form 4 ↗ |
| Apr 29, 2025 | Douglas E. Coltharp EVP & Chief Financial Officer | EHC Encompass Health Corporation | Sale | 13,402 | $115.51 | $1.5M Sale | Form 4 ↗ |
| Apr 29, 2025 | Douglas E. Coltharp EVP & Chief Financial Officer | EHC Encompass Health Corporation | Sale | 26,239 | $114.78 | $3.0M Sale | Form 4 ↗ |
| Feb 13, 2025 | Andrew L. Price Chief Accounting Officer | EHC Encompass Health Corporation | Sale | 5,042 | $98.29 | $495.6K Sale | Form 4 ↗ |
27 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:45 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances